Adopted opinions and previous consultations on applications for authorisation

Adopted opinions and previous consultations on applications for authorisation

Adopted opinions and previous consultations on applications for authorisation

This page provides further information on the applications for authorisation or review reports, which have undergone consultation. The applications for authorisation are in the opinion development phase until the final opinions of the Committees for Risk Assessment and Socio-economic Analysis have been adopted and sent to the European Commission. Its decision-making process can be followed through the comitology register, where further information is published about the REACH Committee's past and upcoming meetings.

On 1 February 2020, the United Kingdom (UK) withdrew from the EU. The transition period provided by the withdrawal agreement ended on 31 December 2020. As of 1 January 2021, an application for an authorisation submitted by a person established in the UK (except Northern Ireland) is no longer valid in the EU, unless that application has been transferred to a legal entity established in the EU or Northern Ireland before the end of the transition period. Therefore, authorisation applications and decisions in so far as these concern persons established in the UK (except Northern Ireland) are no longer considered valid. 

 

There are currently no ongoing consultations.
 
0320-01 Initial Chromium trioxide 215-607-8 1333-82-0 Fratelli Creola S.r.l. Use of chromium trioxide for electroplating of metal substrates with the purpose to creating a long-lasting high durability surface with bright (shiny) or matte look for sanitary and industrial applications Opinion development Details
0262-02 Initial Chromium trioxide 215-607-8 1333-82-0 Cromoplastica C.M.C. S.r.l. Use of chromium trioxide for electroplating of plastic substrates to achieve a protective and durable surface with a silvery finish Opinions adopted Details
0262-01 Initial Chromium trioxide 215-607-8 1333-82-0 Cromoplastica C.M.C. S.r.l. Use of chromium trioxide for etching of plastic substrates as a key pre-treatment step for creating an electrically conductive surface to enable electroplating Opinions adopted Details
0305-01 Initial Chromium trioxide 215-607-8 1333-82-0 Meoni e Bartoletti S.p.A. Use of Chromium Trioxide for the hard-chrome plating of hydraulic and pneumatic cylinders for various applications, and inner tubes of motorbike front suspension for the automotive industry. Opinion development Details
0102-01 Initial Chromium trioxide 215-607-8 1333-82-0 Clariant Produkte (Deutschland) GmbH Use of chromium trioxide in a catalyst for the dehydrogenation of propane to propene Commission decided Details
0033-01 Initial Chromium trioxide 215-607-8 1333-82-0 Oy Kromatek Ab; Kova-Kromi Oy; CrTe-Plating Oy; Saizeri Plating Oy; Turun Kovakromi Oy; Veljekset Wallenius Oy; Pirkan Kovakromaus Oy Use of chromium trioxide in Cr(VI) based functional plating Commission decided Details
0064-01 Initial Chromium trioxide 215-607-8 1333-82-0 HAPOC GmbH & Co KG Use of chromium trioxide in dissolved and solid form to produce aqueous solutions of any composition for industrial application. Opinions adopted Details
0067-01 Initial Chromium trioxide 215-607-8 1333-82-0 Abloy Oy Use of chromium trioxide in electroplating of mechanical and electromechanical cylinders, cam- and padlocks, electromechanical lock cases and architectural hardware. Commission decided Details
0127-01 Initial Chromium trioxide 215-607-8 1333-82-0 MAHLE Ventiltrieb GmbH
MAHLE Polska Sp. z o.o.
Use of chromium trioxide in functional chrome plating of valves used in engines of light gasoline and diesel vehicles and in heavy duty diesel combustion engines Commission decided Details
0093-01 Initial Chromium trioxide 215-607-8 1333-82-0 HAPOC GmbH & Co KG Use of chromium trioxide in solid form and in aqueous solution of any composition to modify the properties of surfaces made of brass, bronze, copper and other copper alloys for medical engineering, aviation and automation products Commission decided Details
0064-04 Initial Chromium trioxide 215-607-8 1333-82-0 HAPOC GmbH & Co KG Use of Chromium trioxide in solid form and in aqueous solution of any composition to modify the properties of surfaces made of metal or plastic, with or without current flow, in category I. Opinions adopted Details
0064-03 Initial Chromium trioxide 215-607-8 1333-82-0 HAPOC GmbH & Co KG Use of chromium trioxide in solid form and in aqueous solution of any composition to modify the properties of surfaces made of metal or plastic, with or without current flow, in category II. Opinions adopted Details
0064-02 Initial Chromium trioxide 215-607-8 1333-82-0 HAPOC GmbH & Co KG Use of Chromium trioxide in solid form and in aqueous solution of any composition to modify the properties of surfaces made of metal or plastic, with or without current flow, in category III. Opinions adopted Details
0092-01 Initial Chromium trioxide 215-607-8 1333-82-0 HAPOC GmbH & Co KG Use of chromium trioxide in solid form and in aqueous solution of any composition to modify the properties of surfaces made of plastic, with or without current flow Opinions adopted Details
0267-01 Initial Chromium trioxide 215-607-8 1333-82-0 SPGPrints B.V. Use of Cr(VI) in an integrated process to create a hard surface with selective adhesion properties on mandrels used to manufacture screens for Rotary Screen Printing (RSP) for textile and other (printing) applications Opinions adopted Details
0148-01 Initial Pitch, coal tar, high temp. 266-028-2 65996-93-2 DEZA a.s. Use of CTPht as a binder in the manufacture of clay targets Commission decided Details
0147-01 Initial Pitch, coal tar, high temp. 266-028-2 65996-93-2 BILBAINA DE ALQUITRANES, S.A. Use of CTPht as a binder in the manufacture of clay targets Commission decided Details
0152-01 Initial Pitch, coal tar, high temp. 266-028-2 65996-93-2 Rain Carbon bvba Use of CTPht for manufacture of formulations for various industrial uses Commission decided Details
0151-01 Initial Pitch, coal tar, high temp. 266-028-2 65996-93-2 Rain Carbon Germany GmbH [name of applicant in the original application: RÜTGERS Germany GmbH updated due to a notified change of corporate name] Use of CTPht for manufacture of formulations for various industrial uses Commission decided Details
0150-01 Initial Pitch, coal tar, high temp. 266-028-2 65996-93-2 Koppers Denmark ApS Use of CTPht for manufacture of formulations for various industrial uses Commission decided Details
0153-01 Initial Pitch, coal tar, high temp. 266-028-2 65996-93-2 BILBAINA DE ALQUITRANES, S.A. Use of CTPht for manufacture of formulations for various industrial uses Commission decided Details
0149-01 Initial Pitch, coal tar, high temp. 266-028-2 65996-93-2 Industrial Quimica del Nalon, S.A. Use of CTPht for manufacture of formulations for various industrial uses Commission decided Details
0006-01 Initial Dibutyl phthalate (DBP) 201-557-4 84-74-2 Sasol-Huntsman GmbH & Co. KG Use of DBP as an absorption solvent in a closed system in the manufacture of maleic anhydride Commission decided Details
0005-01 Initial Dibutyl phthalate (DBP) 201-557-4 84-74-2 DEZA a.s. Use of DBP as an absorption solvent in a closed system in the manufacture of maleic anhydride Commission decided Details
0005-02 Initial Dibutyl phthalate (DBP) 201-557-4 84-74-2 DEZA a.s. Use of DBP in propellants
Formulation: Industrial use of DBP as a burning rate surface moderant, plasticiser and/or coolant in the formulation of nitrocellulose-based propellant grains.
Use at industrial site: Industrial use of DBP-containing propellant grains in manufacture of ammunition for military and civilian uses, and pyrocartridges for aircraft ejection seat safety systems [includes propellants for police force ammunition and excludes propellants intended for manual, private reloading of ammunition cartridges by civilian users, i.e., licensed individual sports shooters and hunters. No direct consumer use of DBP or its mixtures is covered by this Use.]
Commission decided Details
0352-03 Initial Bis(2-ethylhexyl) phthalate 204-211-0 117-81-7 Baxter SA; Baxter Healthcare SA; Gambro Dasco SpA; Baxter (Malta) Trading Co Ltd Use of DEHP-based mixtures as a lubricating/sealing agent for the insertion of port closures into empty bags and assembly/connection of parts, that are used in immediate packaging of medicines Opinion development Details
0352-02 Initial Bis(2-ethylhexyl) phthalate 204-211-0 117-81-7 Baxter SA; Baxter Healthcare SA; Gambro Dasco SpA; Baxter (Malta) Trading Co Ltd Use of DEHP-containing plastics for immediate packaging of medicinal products Opinion development Details
0009-01 Initial Diarsenic trioxide 215-481-4 1327-53-3 Boliden Kokkola Oy Use of diarsenic trioxide in the purification of metal impurities from the leaching solution in the zinc electrowinning process Commission decided Details
0116-01 Initial Dichromium tris(chromate) 246-356-2 24613-89-6 HAAS GROUP INTERNATIONAL SP. Z.O.O [application transferred from: “Wesco Aircraft EMEA, LTD (UK)” due to a notified legal entity change] Use of dichromium tris(chromate) for chemical conversion coating applications by aerospace and defence companies and their associated supply chains Commission decided Details
0045-02 Initial Dichromium tris(chromate) 246-356-2 24613-89-6 Henkel AG & Co. KGaA
Henkel Global
Supply Chain B.V.
Use of dichromium tris(chromate) for surface treatment of metals such as aluminium, steel, zinc, magnesium, titanium, alloys, composites, sealings of anodic films. Commission decided Details
0232-01 Initial Dichromium tris(chromate) 246-356-2 24613-89-6 Monroe Czechia s.r.o. Use of dichromium tris(chromate) in a post-treatment step of the autodeposition coating process of shock absorbers for automotive vehicles. Opinions adopted Details
0085-01 Initial Bis(2-methoxyethyl) ether (Diglyme) 203-924-4 111-96-6 Life Technologies AS Use of diglyme as a process chemical in the manufacture of Dynabeads. Commission decided Details
0084-01 Initial Bis(2-methoxyethyl) ether (Diglyme) 203-924-4 111-96-6 Roche Diagnostics GmbH Use of diglyme as a process chemical in the manufacture of one specific type of Dynabeads® used in immunodiagnostic assays (in vitro diagnostic) Commission decided Details
0089-01 Initial Bis(2-methoxyethyl) ether 203-924-4 111-96-6 PMC ISOCHEM [application transferred from original Applicant: ISOCHEM due to a notified legal entity change] Use of diglyme as a process solvent in one step of the manufacturing of an Active Pharmaceutical Ingredient used in an anti-protozoal drug Commission decided Details
0125-01 Initial Bis(2-methoxyethyl) ether 203-924-4 111-96-6 N.V. Ajinomoto OmniChem S.A. Use of diglyme as a solvent for the synthesis of the anti-HIV active pharmaceutical ingredient (API) dapivirine. Commission decided Details
0061-01 Initial Bis(2-methoxyethyl) ether (Diglyme) 203-924-4 111-96-6 Novartis Ringaskiddy Limited Use of diglyme as solvent in the manufacturing process of an intermediate for further conversion into a pharmaceutical compound used in medicinal products for treatment of respiratory diseases Commission decided Details
0154-04 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - Siemens Healthcare Diagnostics Products GmbH Use of IVD-kit reagents on diagnostic analyser systems Commission decided Details
0154-05 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - Siemens Healthcare Diagnostics Products GmbH Use of IVD-wash solutions on diagnostic analyser systems Commission decided Details
0156-01 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - Sanofi Pasteur Use of Octoxynol-9 for virus splitting and inactivation step in the manufacturing of influenza vaccines Commission decided Details
0171-03 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - Roche Diagnostics GmbH Use of Octyl- and Nonylphenolethoxylates in in vitro diagnostic (IVD) assays specified in Appendix 1 to the AoA. Commission decided Details
0171-04 Initial 4-Nonylphenol, branched and linear, ethoxylated - - Roche Diagnostics GmbH Use of Octyl- and Nonylphenolethoxylates in in vitro diagnostic (IVD) assays specified in Appendix 1 to the AoA. Commission decided Details
0171-01 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - Roche Diagnostics GmbH Use of Octyl- and Nonylphenolethoxylates in the formulation and filling of in vitro diagnostic (IVD) assays specified in Appendix 1 to the AoA. Commission decided Details
0171-02 Initial 4-Nonylphenol, branched and linear, ethoxylated - - Roche Diagnostics GmbH Use of Octyl- and Nonylphenolethoxylates in the formulation and filling of in vitro diagnostic (IVD) assays specified in Appendix 1 to the AoA. Commission decided Details
0171-05 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - Roche Diagnostics GmbH Use of Octyl- and Nonylphenolethoxylates in the production of proteins and the conjugation of latex beads, both being used as components or for the production of components of in vitro diagnostic (IVD) assays, research or quality control products and other, e.g. analytical applications (processes specified in Appendix 1 to the AoA) Commission decided Details
0171-06 Initial 4-Nonylphenol, branched and linear, ethoxylated - - Roche Diagnostics GmbH Use of Octyl- and Nonylphenolethoxylates in the production of proteins and the conjugation of latex beads, both being used as components or for the production of components of in vitro diagnostic (IVD) assays, research or quality control products and other, e.g. analytical applications (processes specified in Appendix 1 to the AoA) Commission decided Details
0196-01 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - Vetter Pharma-Fertigung GmbH & Co. KG Use of Octylphenolethoxylates as emulsifier in the siliconisation of glass containers (syringes and cartridges) used as primary packaging material for 44 medicinal products of several pharmaceutical companies listed in the confidential Appendix 1 to the AoA. These products cover several therapeutic areas, and approx. 40 % of them are listed on the WHO Model List of Essential Medicines (EML). Commission decided Details
0160-01 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - Roche Diagnostics GmbH Use of Octylphenolethoxylates as emulsifier in the siliconisation of glass containers used as primary packaging for medicinal products (NeoRecormon® and MIRCERA®). Commission decided Details
0159-01 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - Nuova Ompi S.r.l. unipersonale Use of Octylphenolethoxylates as emulsifier in the siliconisation of glass containers used as primary packaging for one specific medicinal product (NeoRecormon®) of one pharmaceutical company. Commission decided Details
0161-01 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - Vetter Pharma-Fertigung GmbH & Co. KG Use of Octylphenolethoxylates as emulsifier in the siliconisation of glass containers used as primary packaging for two specific medicinal products (NutropinAq® and Lucentis®) of one pharmaceutical company. Commission decided Details
0173-01 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - Siemens Healthcare Diagnostics Products Ltd - [Application void as of 01/01/2021] Use of OPE as detergent in the production of bead components for in-vitro diagnostic kits for an immunoassay platform Application void as of 01 January 2021 Details